金融界消息 截至2025年7月31日收盘，博苑股份（301617）报收于38.4元，下跌1.49%，换手率4.43%， 成交量1.48万手，成交金额5714.26万元。 资金流向方面，今日主力资金净流出1137.30万元，占比成交额19.9%。其中，超大单净流出136.53万 元、占成交额2.39%，大单净流出1000.77万元、占成交额17.51%，中单净流出流出33.10万元、占成交 额0.58%，小单净流入1170.40万元、占成交额20.48%。 通过天眼查大数据分析，山东博苑医药化学股份有限公司共对外投资了2家企业，参与招投标项目85 次，知识产权方面有商标信息47条，专利信息71条，此外企业还拥有行政许可119个。 来源：金融界 博苑股份最新一期业绩显示，截至2025一季报，公司营业总收入3.20亿元、同比增长4.02%，归属净利 润4907.75万元，同比减少4.05%，扣非净利润4849.16万元，同比减少4.87%，流动比率6.461、速动比率 5.255、资产负债率11.22%。 天眼查商业履历信息显示，山东博苑医药化学股份有限公司，成立于2008年，位于潍坊市，是一家以从 事医药制造业为 ...

Group 1: Iodine Resource Distribution and Applications - The global iodine industry shows a clear regional distribution, with major production concentrated in Chile, Japan, and the United States. Chile is the largest iodine producer due to its unique nitrate mineral resources [2] - Iodine and iodides serve as essential functional raw materials across various industries, including pharmaceuticals, electronics, and chemicals. In the pharmaceutical sector, iodides are crucial for producing contrast agents, disinfectants, and antibiotics [3] Group 2: Company Development Plans - The company aims to integrate its main business with resource utilization, focusing on "technological innovation and green development" as strategic goals. It emphasizes collaborative innovation between industry and academia to reduce costs and enhance efficiency [3] - Future plans include increasing investment in technology research and development, particularly in the fine chemical sector, with a focus on pharmaceuticals. The company seeks to leverage opportunities from the new development pattern of domestic and international dual circulation [3]

Core Viewpoint - The company has completed the absorption and merger of Weifang Rongyuan, which has been officially deregistered, and this will not have a substantial impact on the company's consolidated financial statements or operational performance [1] Group 1 - The company received a deregistration notice from the Shouguang Administrative Approval Service Bureau on July 2, 2025, regarding Weifang Rongyuan [1] - The deregistration procedures for Weifang Rongyuan have been completed, and all assets, debts, business operations, personnel, and related qualifications have been inherited by the company [1] - The consolidation scope of the company's financial statements will change accordingly, but it will not have a significant impact on the company's financial and operational situation [1]

证券代码：301617 证券简称：博苑股份 公告编号：2025-034 山东博苑医药化学股份有限公司 关于完成吸收合并全资子公司的公告 2025 年 7 月 2 日，公司收到寿光市行政审批服务局下发的关于潍坊荣源《准 予注销登记通知书》，潍坊荣源工商注销登记手续已办理完毕。至此潍坊荣源依 法注销，本次吸收合并事项已完成，潍坊荣源全部资产、债权债务、业务、人员 和相关资质等均已由博苑股份承继，公司合并报表范围将发生相应变化，但不会 对公司合并报表产生实质性影响，不会对公司的财务及经营情况产生重大影响。 三、备查文件 《准予注销登记通知书》。 特此公告。 山东博苑医药化学股份有限公司 董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、吸收合并概述 山东博苑医药化学股份有限公司（以下简称"公司"或"博苑股份"）于 2025 年 3 月 21 日召开第二届董事会第八次会议、第二届监事会第六次会议，于 2025 年 4 月 7 日召开 2025 年第二次临时股东会，审议通过了《关于公司吸收合 并全资子公司的议案》，同意博苑股份吸收合并全资子公司潍坊荣源新材料有 ...

Summary of Key Points Core Viewpoint - The report highlights a significant decline in the number of shareholders for many companies listed on the ChiNext board, indicating a trend of shareholder concentration and potential market volatility [1][2]. Group 1: Shareholder Trends - A total of 246 ChiNext stocks reported their latest shareholder numbers as of June 20, with 141 stocks experiencing a decline in shareholder count compared to June 10, and 15 of these stocks saw a decrease of over 10% [1]. - The stock with the largest decline in shareholder count was Jieya Co., with a decrease of 22.08% to 8,867 shareholders, and a cumulative drop of 15.10% in stock price since the concentration began [1][2]. - Other notable declines include Boyuan Co. with a 20.64% drop to 14,248 shareholders and Qide New Materials with an 18.75% decrease to 7,823 shareholders [1][2]. Group 2: Market Performance - Among the stocks with concentrated shareholding, the average increase since June 11 is 0.92%, with top performers including Haitai Technology, Boshuo Technology, and Hengshuai Co., which saw increases of 24.92%, 21.58%, and 20.59% respectively [2]. - The industries with the most concentrated stocks include machinery, basic chemicals, and pharmaceutical biology, with 20, 14, and 13 stocks respectively [2]. Group 3: Leverage and Funding - As of June 25, 37 stocks with concentrated shareholding attracted leveraged funds, with notable increases in financing balances for Zhongying Electronics, Qide New Materials, and Haitai Technology, which grew by 88.45%, 75.53%, and 66.61% respectively [2].

Summary of Key Points Core Viewpoint - The report highlights a significant decline in the number of shareholders for many companies listed on the ChiNext board, indicating a trend of shareholder concentration and potential market implications for these stocks [1][2][3]. Group 1: Shareholder Changes - A total of 209 ChiNext stocks reported their latest shareholder numbers as of June 20, with 126 stocks experiencing a decline in shareholder count compared to June 10, and 11 of these stocks seeing a decrease of over 10% [1]. - The stock with the largest decline in shareholder count is Jieya Co., with a decrease of 22.08% to 8,867 shareholders, and a cumulative drop of 13.97% in stock price since the concentration began [1]. - Other notable declines include Boyuan Co. (20.64% decrease) and Qide New Materials (18.75% decrease) [1][2]. Group 2: Market Performance - Among the concentrated stocks, the average price increase since June 11 is 0.31%, with top performers including Haitai Technology (25.88% increase), Hengshuai Co. (20.28% increase), and Boshuo Technology (18.98% increase) [2]. - The industries with the most concentrated stocks include machinery, electrical equipment, and computers, with 18, 12, and 11 stocks respectively [2]. Group 3: Leverage and Funding - As of June 24, 33 concentrated stocks have attracted leveraged funds, with notable increases in financing balances for Zhongying Electronics (88.68%), Haitai Technology (69.45%), and Qide New Materials (63.07%) [2]. Group 4: Continuous Decline in Shareholder Numbers - Companies like Zhongjian Huaneng and Kema Technology have seen continuous declines in shareholder numbers for 15 and 10 periods respectively, with cumulative declines of 20.86% and 23.30% [2][3]. - The report indicates that 38 ChiNext stocks have shown a continuous decline in shareholder numbers for more than three periods, with some stocks experiencing declines for up to 15 periods [1].

证券代码：301617 证券简称：博苑股份 公告编号：2025-033 山东博苑医药化学股份有限公司 山东博苑医药化学股份有限公司（以下简称"公司"）分别于 2025 年 4 月 23 日、2025 年 5 月 15 日召开第二届董事会第九次会议和 2024 年年度股东会， 审议通过了《关于变更公司注册资本、修订<公司章程>并办理工商变更登记的议 案》，具体内容详见公司于 2025 年 4 月 25 日在中国证券监督管理委员会指定信 息披露网站巨潮资讯网（http://www.cninfo.com.cn）披露的《关于变更公司注 册资本、修订<公司章程>并办理工商变更登记的公告》（公告编号：2025-026）。 1、名 称：山东博苑医药化学股份有限公司 7、住 所：山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200 米 8、经营范围：许可项目：危险化学品生产；危险废物经营；危险化学品经 营；饲料添加剂生产；食品添加剂生产；货物进出口；技术进出口；发电、输电、 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2、统一 ...

Group 1 - The core viewpoint of the news is that Hongshang Asset has conducted research on a listed company, Boyuan Co., focusing on its increased R&D investment and technological innovation strategies [1] - Boyuan Co. plans to enhance its R&D capabilities by increasing investment and expanding its R&D team, particularly by attracting high-end technical talent [1] - The company’s main products include inorganic iodides such as potassium iodide, potassium iodate, sodium iodide, and hydrogen iodide, which are used in pharmaceuticals, pesticides, feed, and optoelectronic materials [1] Group 2 - Boyuan Co.'s organic iodide product, trimethyl iodide, is primarily used as a protecting group in organic synthesis, especially in the production of antibiotics [1] - The pricing of iodide products is mainly based on the market price of refined iodine, determined through negotiations with customers [1] - The company is working on a high-end organic iodine and bromine new materials project with an annual capacity of 4,100 tons, which includes products like methyl iodide and dimethyl iodide [1]

Group 1: Research and Development - The company's R&D expenses increased year-on-year due to a focus on enhancing independent R&D capabilities and increasing investment in technological innovation [2] - The company is expanding its R&D team and optimizing its structure to ensure a leading advantage in key technologies [2] Group 2: Product Applications - The main inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, and hydrogen iodide, which are used in pharmaceuticals, pesticides, feed, and optoelectronic materials [2] - The organic iodide product trimethyl iodide is primarily used as a protecting group in organic synthesis, particularly in the production of antibiotics [2] Group 3: Pricing Strategy - The pricing of iodide products is mainly based on the market price of refined iodine and is determined through negotiations with customers [3] Group 4: Production Capacity - The high-end organic iodine and bromine new materials project has an annual production capacity of 4,100 tons [3]

Market Overview - As of June 12, the Shanghai Composite Index closed at 3402.66 points, with a slight increase of 0.34 points, representing a change of 0.01% [1] - The Shenzhen Component Index closed at 10234.33 points, down by 11.69 points, a decrease of 0.11% [1] - The ChiNext Index closed at 2067.15 points, up by 5.29 points, reflecting an increase of 0.26% [1] Trading Activity - A total of 128 A-shares had a turnover rate exceeding 20% on the same day, indicating significant trading activity [1] - Notably, C Haiyang and Zhongke Magnetic had turnover rates exceeding 50%, suggesting a high level of liquidity and interest in these stocks [1] Top Performing Stocks - C Haiyang (603382) had a closing price of 55.97 yuan with a turnover rate of 85.43% and a remarkable increase of 386.70% [1] - Zhongke Magnetic (301141) closed at 68.13 yuan, with a turnover rate of 67.96% and a gain of 3.20% [1] - Yingsite (301622) closed at 97.32 yuan, achieving a turnover rate of 60.53% and a rise of 20.00% [1] - Jiangnan New Materials (603124) closed at 48.20 yuan, with a turnover rate of 57.58% and an increase of 4.83% [1] - Xiongdi Technology (300546) closed at 34.41 yuan, with a turnover rate of 56.64% and a gain of 7.20% [1] Additional Notable Stocks - Kangliyuan (301287) closed at 50.52 yuan, with a turnover rate of 48.58% and a slight decrease of 0.26% [1] - Qingmu Technology (301110) closed at 72.42 yuan, achieving a turnover rate of 46.33% and a rise of 20.00% [1] - Baixinglong (833075) closed at 46.99 yuan, with a turnover rate of 44.54% and an increase of 29.99% [1] - Hengbao Co., Ltd. (002104) closed at 11.82 yuan, with a turnover rate of 44.51% and a gain of 2.34% [1] - Guokang Biochemical (300804) closed at 61.10 yuan, with a turnover rate of 42.76% and a slight increase of 1.08% [1]